| Literature DB >> 34402777 |
Spencer A Bruce1, Yen-Hua Huang2, Pauline L Kamath3, Henriette van Heerden4, Wendy C Turner5.
Abstract
Entities:
Keywords: AMR; Bacillus anthracis; bacterial genomics; natural selection
Mesh:
Substances:
Year: 2021 PMID: 34402777 PMCID: PMC8549369 DOI: 10.1099/mgen.0.000616
Source DB: PubMed Journal: Microb Genom ISSN: 2057-5858
Fig. 1.AMR genes identified in the whole‐chromosome tree of 356 global isolates (a). Primary clusters are divided into their numbered nested clades by grey lines. The key on the right lists the ten AMR genes identified. Outer rings reflect presence (colour) or absence (white) of each gene across all isolates in the phylogeny. A world map depicting the prevalence of AMR genes is depicted in (b). Each circle represents an AMR gene coloured according to the key and figure above. Percentages represent the total proportion of isolates from each continent where the respective AMR gene was identified (including North America, South America, Europe, Asia and Oceania). See Fig. S1 for a key to previously established classification schemes.
AMR genes and their definitions from the Comprehensive Antibiotic Resistance Database (CARD)
|
Name |
Resistance mechanism |
Accession |
Definition |
|---|---|---|---|
|
|
Antibiotic inactivation |
ARO:3003072 |
A chromosomally encoded macrolide phosphotransferase that inactivates macrolides such as erythromycin, clarithromycin, azithromycin |
|
|
Antibiotic inactivation |
ARO:3000090 |
A chromosomally encoded beta-lactamase that hydrolyses penicillins |
|
|
Antibiotic inactivation |
ARO:3000172 |
A thiol transferase that leads to fosfomycin resistance |
|
|
Antibiotic inactivation |
ARO:3004189 |
A chromosomally encoded beta-lactamase that has penicillin-, cephalosporin- and carbapenem-hydrolysing abilities |
|
|
Antibiotic target protection |
ARO:3004476 |
An ABC-F ATPase ribosomal protection protein shown to confer resistance to lincomycin and streptogramin A virginiamycin |
|
|
Antibiotic inactivation |
ARO:3002878 |
A zinc metallo-beta-lactamase that hydrolyses a large number of penicillins and cephalosporins |
|
|
Antibiotic inactivation |
ARO:3000979 |
A broad-spectrum beta-lactamase found in many species of bacteria |
|
|
Antibiotic target alteration |
ARO:3004146 |
A |
|
|
Antibiotic target replacement |
ARO:3002868 |
A plasmid-encoded dihydrofolate reductase |
|
|
Antibiotic inactivation |
ARO:3001772 |
A beta-lactamase |
Fig. 2.Prophage sequences identified in whole‐chromosome tree of 356 global isolates. Primary clusters are divided into their numbered nested clades by grey lines. The key on the right indicates the phage sequence present for each isolate, numbered according to their order from the inside of the ring to the outside. Colour indicates whether the phage sequence was determined to be intact, questionable or incomplete. Criteria related to this categorization can be found in Table S1. See Fig. S1 for a key to previously established classification schemes.
Fig. 3.Importance of the covariates in defining population genomic architecture for all primary clusters combined (a) and for each primary cluster on its own (b) by the RF classifier.
Information for SNPs that exhibit a potentially high-impact effect and fall within clustered mutations across the genome; positions are relative to the Ames Ancestor reference genome (NCBI accession: AE017334.2)
|
Cluster |
Position |
Reference |
Alternate |
Comparative effect |
Gene/product |
|---|---|---|---|---|---|
|
1 |
1 260 604 |
C |
T |
Stop gained |
DNA-binding response regulator |
|
1 292 469 |
C |
A |
Stop gained |
Stage 0 sporulation regulatory protein | |
|
2 |
3 140 849 |
A |
T |
Stop gained |
TPR domain protein |
|
5 and 6 |
1 748 642 |
A |
T |
Stop gained |
Chlorohydrolase family protein |
|
2 423 864 |
T |
C |
Start lost |
Hypothetical protein |
Information for non-synonymous SNPs in virulence genes across the plasmids; positions are relative to the Ames Ancestor reference genome (NCBI accession: AE017336)
|
Cluster.clade |
Position |
Plasmid |
Reference |
Alternate |
Comparative effect |
Gene/product |
|---|---|---|---|---|---|---|
|
6.3 |
123 936 |
pXO1 |
A |
T |
Missense mutation |
|
|
6.3 |
124 007 |
pXO1 |
A |
G |
Missense mutation |
|
|
4 |
145 471 |
pXO1 |
C |
T |
Missense mutation |
|
|
5 |
145 577 |
pXO1 |
C |
T |
Missense mutation |
|